News Tag: Corporate Information

“We are receiving valuable ongoing feedback from pilot projects and our partners in the Nordic countries and Italy, which means we can prioritise the right issues to further improve Dosell. In the light of the feedback we have documented, the past six months have been a period of intense development and investments in products, technology and software. IZafe group is reinforcing its leading position in a powerfully growing market through ongoing investments in products and the market, combined with close cooperation with partners,” says Anders Segerström, CEO of iZafe Group.

The sale of the company’s security business, iZafe Security, created the necessary scope for continuous investments in product development and commercialisation of Dosell. The company has released numerous new features in pace with several public procurement processes and the launch of additional pilot projects. In parallel, the partner network has been expanded and international establishment is growing.

A selection of recently developed new or updated features:

• A new safety feature that provides the option to dispense dose-packed sachets using the “wait until button is pressed” has been launched.
  • When it is time to dispense medication, the user must press the button to get the medicine. If they do not press the button within a predetermined time, the medication is locked inside Dosell.
• A demo mode has been developed and introduced to make it easier to present Dosell’s features and alarm handling at training sessions, for example.
• The option to dispense dose-packed sachets at non-scheduled times makes the system more flexible for users, so that Dosell adjusts to their daily routines and not the reverse.
• A feature for accessing information about when the next dose will be dispensed.
• Improved handling of minutes in OCR.
• The red LED light that shines in the dose compartment when the user has not removed the sachet in time goes out automatically when the sachet is removed. In the past, the user had to press a button to turn off the light. 
• Validation of Finnish dose-packed sachets.
• The company has invested in and developed software and systems, including other functionalities to improve how Dosell communicates with the server, making easier to support and facilitate the work of partners.
• A feature to determine whether the placement of the dispensing robot should be changed to improve coverage.
• Medication dispensing robots with built-in rechargeable batteries and 48-hour battery backup will be launched early next year to further enhance safety.
• A simplified start-up process for new users to connect to Dosell will be launched in Q1 2021.

The results of the pilot project will be used as decision input for a future commercial arrangement based on an integrated solution involving automated dispensing of medication in dose-packed sachets from dispensing robots. The goal is to create a full-coverage solution for users while reducing the need for home health visits in connection with taking medication.

“We are proud of the partnership and are looking forward to working with Vivago to further develop the industry in Finland. In the first stage, we will perform a joint market analysis to build knowledge about the Finnish market. We are especially pleased that our partnership has already resulted in a strategically important pilot project.” comments Anders Segerström CEO, iZafe Group.

Major training initiatives were carried out in the autumn to prepare for the pilot project, which is expected to begin immediately after the end of the year. Twenty people will be using Dosell to manage their medication during the pilot project.

“We are delighted by the partnership between Vivago and iZafe. The partnership will be a key step in Vivago’s future ventures in the digitalisation of medication dispensing in Finland while reinforcing our service offering. The partnership with iZafe and their Dosell digital medication dispenser makes a more comprehensive service offering to our customers in Finland possible. Vivago’s health and well-being solutions combined with Dosell will enhance safety and provide better care to our elderly people.” Says Niina Vilkas, CEO Vivago Ltd.

About Vivago
Vivago develops smart safety and wellbeing solutions for preventive care by monitoring users’ health status in real-time and wellbeing 24/7. The Vivago solution includes all features required for nurse call systems and covers the entire chain of care from home care and assisted living to rehabilitation centres and hospitals. More than 100,000 people use Vivago solutions every single day. Full digitalisation of health status monitoring is opening a revolutionary path to changing care delivery from reactive to preventive while tailoring entirely patient-centred and results-driven care.

Please send your questions to  before 17:00 (5 p.m.) CET on November 10, 2020. You can also use an online form to send your questions. This form is available on iZafe's website, Investor Relations page.

The current patent application could provide the company with future patents in a large number of countries including Sweden, other parts of Europe and the USA. The fact that iZafe has a patent pending already in itself affords important protection for the company’s further development of Dosell as a digital platform and additionally strengthens iZafe’s position in the market.

“The digitalization of healthcare has accelerated in recent years, and iZafe is a leading provider of medication dose dispensing for those who want to manage their medication themselves. By protecting the further development of Dosell into a digital hub for a future digital clinic in the home, we are strengthening our position as well as our patent portfolio,” says Anders Segerström, CEO of iZafe Group.

The patent application relates to the development of a system for dispensing medication via the Dosell robot in which the dose of medication dispensed is adjusted based on current patient-specific information.

“We are convinced that the ecosystem that Dosell provides via medication dispensing and the SaaS-based services is just the start of a rapid digitalization of many measurements that can be monitored by the doctor responsible for the patient via the Dosell app. The fact that we now have a patent pending in this area is an important part of our long-term strategy for positioning iZafe as a leading player in the digitalization of home and remote healthcare. Publication of the patent application that was filed 18 months ago strengthens our position in the market while also protecting us from competitors,” says Anders Segerström.

Future digital care in the home
We are living longer and longer, and an aging population increases the need for care and social services. Society aims to deliver increasing quality for our seniors and an important part of this ambition is to offer an increasing level of care in the home. iZafe’s vision of a “digital clinic in the home” will only be possible if important information about the patient’s state of health can be measured and communicated to the treating doctor.

This further development of Dosell allows sensors in the home to take the patient’s readings and communicate these via iZafe’s cloud-based solution. The treating doctor can then make sure that the correctly adjusted dose is always given to the patient via Dosell. The new technology further increases patient safety in respect of the dosing and dispensing of medication. Using Dosell as a hub realizes the vision of a digital doctor’s round in the home, which will be particularly important for patients being treated for conditions such as dementia, complex heart problems, diabetes, Parkinson’s and MS.

“Through Dosell, iZafe has already set a new standard for digital medication dispensing and future patents will enable the company to revolutionize care – above all in the home and especially for seniors, people with multiple conditions and patients on multiple medications,” says Dr Göran Sjönell, doctor in general medical practice, co-founder of iZafe Group and inventor of Dosell.